Literature DB >> 16091846

The effect of isoforms of the cell polarity protein, human ASIP, on the cell cycle and Fas/FasL-mediated apoptosis in human hepatoma cells.

Y Hu1, C Fang, Y Xu.   

Abstract

Human ASIP (hASIP) is expressed as numerous alternative splicing isoforms and there is an atypical protein kinease C (aPKC) phosphorylation site in exon 17b of the encoded sequence. We have identified an important role for exon 17b in cancer cells. Our results showed that hASIP-sa and sb had different effects on cell growth and Fas/FasL-mediated apoptosis in BEL-7404 human hepatoma cells. Human ASIP-sa modified the S phase of the cell cycle and might stimulate cell proliferation. Growth inhibition by hASIP-a antisense oligonucleotide-confirmed the positive action of hASIP-sa. Compared with hASIP-sa, hASIP-sb accelerated Fas/FasL-induced apoptosis, examined by sub-G1 accumulation, chromatin condensation, nuclear fragmentation, PARP cleavage, caspase-8 degradation and mitochondria- regulated cell death. Treatment with aPKC inhibitor could enhance Fas/FasL-mediated apoptosis in hASIP-sa-overexpressing cells, suggesting that hASIP-sa and its interaction with aPKC might contribute to the malignant growth and the blocking of Fas/FasL-mediated apoptosis, while hASIP-sb might function as an antagonist of hASIP-sa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091846     DOI: 10.1007/s00018-005-5134-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  4 in total

1.  Trans-regulation of the expression of the transcription factor MtHAP2-1 by a uORF controls root nodule development.

Authors:  Jean Philippe Combier; Françoise de Billy; Pascal Gamas; Andreas Niebel; Susana Rivas
Journal:  Genes Dev       Date:  2008-06-01       Impact factor: 11.361

2.  Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Srinivas Veerla; Mats Jönsson; Inge Bernstein; Ake Borg; Mef Nilbert
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

3.  Alternative splicing and its impact as a cancer diagnostic marker.

Authors:  Yun-Ji Kim; Heui-Soo Kim
Journal:  Genomics Inform       Date:  2012-06-30

Review 4.  Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.

Authors:  Serena Bonomi; Stefania Gallo; Morena Catillo; Daniela Pignataro; Giuseppe Biamonti; Claudia Ghigna
Journal:  Int J Cell Biol       Date:  2013-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.